Multiple symmetric and multiple familial lipomatosis.


Journal

Presse medicale (Paris, France : 1983)
ISSN: 2213-0276
Titre abrégé: Presse Med
Pays: France
ID NLM: 8302490

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 23 06 2021
revised: 20 08 2021
accepted: 12 10 2021
pubmed: 24 10 2021
medline: 16 12 2021
entrez: 23 10 2021
Statut: ppublish

Résumé

Lipomas are the most common soft tissue tumors and are malignant in only 1% of cases. Lipomatosis is defined as the presence of multiple benign lipomas on the body, without lipoatrophy. Their impact on quality of life is significant. Different entities have been described such as symmetrical multiple lipomatosis (MSL), also called Madelung's disease and familial multiple lipomatosis (FML). MSL occurs preferentially in men (but also women) who are alcohol abuser. There are different subtypes of the disease, the most classic of which affects the upper body and the nuchal region with a buffalo hump appearance. A metabolic component with obesity is frequent. In contrast to Dercum's disease, there is no pain. SAOS, complications of the metabolic syndrome and of alcohol abuse including cancers, may be associated and should be screened. FML has been little described in the literature since Brodie's first report in 1846. FML occurs preferentially in the third decade but equally in women and men. Its autosomal dominant component is classically accepted with variable penetrance within the same family. Association with naevi, angiomas, polyneuropathies and with gastrointestinal comorbidities has been reported. Interestingly, and in contrast with most lipodystrophy disorders, the patients show an insulin sensitivity profile. A better understanding of the underlying pathophysiological mechanisms would open up avenues on therapeutic research, since treatments are only symptomatic to date.

Identifiants

pubmed: 34687914
pii: S0755-4982(21)00016-6
doi: 10.1016/j.lpm.2021.104077
pii:
doi:

Substances chimiques

Mitochondrial Proteins 0
GTP Phosphohydrolases EC 3.6.1.-
MFN2 protein, human EC 3.6.1.-

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

104077

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure of Competing Interest The authors declare that they have no competing interest.

Auteurs

Madleen Lemaitre (M)

CHU Lille, Endocrinology, Diabetology and Metabolism, F-59000 Lille, France; Univ. Lille, F-59000 Lille, France. Electronic address: madleen.lemaitre@chru-lille.fr.

Benjamin Chevalier (B)

CHU Lille, Endocrinology, Diabetology and Metabolism, F-59000 Lille, France; Univ. Lille, F-59000 Lille, France.

Arnaud Jannin (A)

CHU Lille, Endocrinology, Diabetology and Metabolism, F-59000 Lille, France; Univ. Lille, F-59000 Lille, France.

Julien Bourry (J)

CHU Lille, Endocrinology, Diabetology and Metabolism, F-59000 Lille, France; Univ. Lille, F-59000 Lille, France.

Stéphanie Espiard (S)

CHU Lille, Endocrinology, Diabetology and Metabolism, F-59000 Lille, France; Inserm U1190, F-59000 Lille, France; Univ. Lille, F-59000 Lille, France.

Marie-Christine Vantyghem (MC)

CHU Lille, Endocrinology, Diabetology and Metabolism, F-59000 Lille, France; Inserm U1190, F-59000 Lille, France; Univ. Lille, F-59000 Lille, France. Electronic address: mc-vantyghem@chru-lille.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH